Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Ophthalmic Eye Drops Market Size study, by Type (Antibiotics, Artificial Tears, Hormones, Others) by Application (Eye diseases, Eyecare, Others) By Purchase Mode (Prescription, OTC), By Eye Diseases (Dry Eye, Glaucoma, Conjunctivitis, Refractive Errors, Others) and Regional Forecasts 2021-2027.

  • BIZ4457844
  • 200 Pages
  • June 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Ophthalmic Eye Drops Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.4% over the forecast period 2021-2027. Ophthalmic Eye drops are used to relieve people suffering from various eye problems such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. An increase in the number of working populations is also leading to several forms of illness including hormonal disbalances. Imbalance in hormone levels also leads to eye and vision problems. Thus, eye drops and lubricants come to the rescue as they are handier, less painful, and are can be used for various eye problems. The National Ambulatory Medical Care Survey indicated that Americans made more than 4 million visits to ambulatory physicians for bacterial conjunctivitis in 2005. Approximately 70% of patients with acute conjunctivitis present to primary and urgent care providers, which accounts for 1% of all primary care office visits. Adenoviruses account for 65 to 90% of cases of viral conjunctivitis. The report presents a positive growth outlook, ongoing restrictions amid the COVID-19 outbreak might hamper sales.

COVID-19 pandemic is expected to negatively impact the ophthalmic eye drops market. Significant reduction in physician office visits and subsequent decline in the number of prescriptions and OTC eye drop purchases are expected to hamper the market growth during the COVID-19 pandemic. Speedy vaccination programs against COVID are expected to enable market recovery in the coming 1-2 years. Lack of health insurance amongst the population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst the rural population about the various ophthalmic disorders such as cataracts. Also, the soaring cases of eye infections have been driving ophthalmic eye drops sales which are likely to increase the market growth during the forecast period.

The regional analysis of the global Ophthalmic Eyedrops market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increase in the prevalence of Glaucoma, cataract, and other ophthalmic disorders. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027. Factors such as the rapid rise in the development of health care infrastructure, rise in the incidence of ophthalmic disorders, and increase in initiatives by its government would create lucrative growth prospects for the Global Ophthalmic Eye Drops Market across the Asia-Pacific region.

Major market player included in this report are:

Pfizer Inc.

Akorn consumer health

Johnson & Johnson

Prestige Consumer Healthcare

Sagar Pharma Kft.

Maya Biotech

Jawa Pharmaceuticals ltd

Neiss Labs Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Antibiotics,

Artificial Tears,

Hormones,

Others

By Application:

Eye diseases

Eyecare,

Others

By Purchase Mode :

Prescription,

OTC,

By Eye Diseases:

Dry Eye,

Glaucoma,

Conjunctivitis,

Refractive Errors,

Others

By Region:

North America

The U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

Ro APAC

Latin America

Mexico

Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2028

Target Audience of the Global Urgent Care Centers Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1.Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2028 (USD Billion)

1.2.1. Ophthalmic Eye Drops Market, by Region, 2019-2028 (USD Billion)

1.2.2. Ophthalmic Eye Drops Market, by Type, 2019-2028 (USD Billion)

1.2.3. Ophthalmic Eye Drops Market, by Application, 2019-2028 (USD Billion)

1.2.4. Ophthalmic Eye Drops Market, by Purchase mode, 2019-2028 (USD Billion)

1.2.5. Ophthalmic Eye Drops Market, by Eye diseases, 2019-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Global Ophthalmic Eye Drops Market Definition and Scope

1.6. The objective of the Study

1.7. Market Definition & Scope

1.7.1. Scope of the Study

1.7.2. Industry Evolution

1.8. Years Considered for the Study

1.9. Currency Conversion Rates

Global Ophthalmic Eye Drops Market Dynamics

1.10. Ophthalmic Eye Drops Market Impact Analysis (2019-2028)

1.10.1. Market Drivers

1.10.1.1. Increase in the number of working populations

1.10.1.2. Hormone imbalance

1.10.2. Market Challenges

1.10.2.1. Lack of health insurance for ophthalmology

1.10.2.2. Covid 19 Pandemic

1.10.3. Market Opportunities

1.10.3.1. Soaring cases of eye infections

Global Ophthalmic Eye Drops Market Industry Analysis

1.11. Porter’s 5 Force Model

1.11.1. Bargaining Power of Suppliers

1.11.2. Bargaining Power of Buyers

1.11.3. The threat of New Entrants

1.11.4. Threat of Substitutes

1.11.5. Competitive Rivalry

1.11.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

1.12. PEST Analysis

1.12.1. Political

1.12.2. Economical

1.12.3. Social

1.12.4. Technological

1.13. Investment Adoption Model

1.14. Analyst Recommendation & Conclusion

Global Ophthalmic Eye Drops Market, by Type

1.1. Market Snapshot

1.2. Global Ophthalmic Eye Drops Market by Type, Performance - Potential Analysis

1.3. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Type 2018-2028 (USD Billion)

1.4. Ophthalmic Eye Drops Market, Sub Segment Analysis

1.4.1. Antibiotics,

1.4.2. Artificial Tears,

1.4.3. Hormones,

1.4.4. Others

Global Ophthalmic Eye Drops Market, by Application

1.5. Market Snapshot

1.6. Global Ophthalmic Eye Drops Market by Application, Performance - Potential Analysis

1.7. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Application 2018-2028 (USD Billion)

1.8. Ophthalmic Eye Drops Market, Sub Segment Analysis

1.8.1. Eye diseases

1.8.2. Eyecare,

1.8.3. Others

Global Ophthalmic Eye Drops Market, by Purchase mode

1.9. Market Snapshot

1.10. Global Ophthalmic Eye Drops Market by Purchase Mode, Performance - Potential Analysis

1.11. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Purchase Mode 2018-2028 (USD Billion)

1.12. Ophthalmic Eye Drops Market, Sub Segment Analysis

1.12.1. Prescription

1.12.2. OTC

Global Ophthalmic Eye Drops Market, by Eye disease

1.13. Market Snapshot

1.14. Global Ophthalmic Eye Drops Market by Eye disease, Performance - Potential Analysis

1.15. Global Ophthalmic Eye Drops Market Estimates & Forecasts by Eye disease 2018-2028 (USD Billion)

1.16. Ophthalmic Eye Drops Market, Sub Segment Analysis

1.16.1. Dry Eye

1.16.2. Glaucoma

1.16.3. Conjunctivitis

1.16.4. Refractive Errors

1.16.5. Others

Global Ophthalmic Eye Drops Market, Regional Analysis

1.17. Ophthalmic Eye Drops Market, Regional Market Snapshot

1.18. North America Ophthalmic Eye Drops Market

1.18.1. U.S. Ophthalmic Eye Drops Market

1.18.1.1. Type breakdown estimates & forecasts, 2018-2028

1.18.1.2. Application breakdown estimates & forecasts, 2018-2028

1.18.1.3. Purchase mode breakdown estimates & forecasts, 2018-2028

1.18.1.4. Eye Disease breakdown estimates & forecasts, 2018-2028

1.18.2. Canada Ophthalmic Eye Drops Market

1.19. Europe Ophthalmic Eye Drops Market Snapshot

1.19.1. U.K. Ophthalmic Eye Drops Market

1.19.2. Germany Ophthalmic Eye Drops Market

1.19.3. France Ophthalmic Eye Drops Market

1.19.4. Spain Ophthalmic Eye Drops Market

1.19.5. Italy Ophthalmic Eye Drops Market

1.19.6. Rest of Europe Ophthalmic Eye Drops Market

1.20. Asia-Pacific Ophthalmic Eye Drops Market Snapshot

1.20.1. China Ophthalmic Eye Drops Market

1.20.2. India Ophthalmic Eye Drops Market

1.20.3. Japan Ophthalmic Eye Drops Market

1.20.4. Australia Ophthalmic Eye Drops Market

1.20.5. South Korea Ophthalmic Eye Drops Market

1.20.6. Rest of Asia Pacific Ophthalmic Eye Drops Market

1.21. Latin America Ophthalmic Eye Drops Market Snapshot

1.21.1. Brazil Ophthalmic Eye Drops Market

1.21.2. Mexico Ophthalmic Eye Drops Market

1.22. Rest of The World Ophthalmic Eye Drops Market

Competitive Intelligence

1.23. Top Market Strategies

1.24. Company Profiles

Pfizer Inc.

1.24.1.1. Key Information

1.24.1.2. Overview

1.24.1.3. Financial (Subject to Data Availability)

1.24.1.4. Product Summary

1.24.1.5. Recent Developments

1.24.2. Akorn consumer health

1.24.3. Johnson and Johnson

1.24.4. Prestige Consumer Healthcare

1.24.5. Sagar Pharma Kft.

1.24.6. Maya Biotech

1.24.7. Jawa Pharmaceuticals Ltd

1.24.8. Neiss Labs ltd

Research Process

1.25. Research Process

1.25.1. Data Mining

1.25.2. Analysis

1.25.3. Market Estimation

1.25.4. Validation

1.25.5. Publishing

1.26. Research Attributes

1.27. Research Assumption

List of Tables

TABLE 1. Global Ophthalmic Eye Drops market, report scope

TABLE 2. Global Ophthalmic Eye Drops market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global Ophthalmic Eye Drops market estimates & forecasts by Type 2018-2028 (USD Billion)

TABLE 4. Global Ophthalmic Eye Drops market estimates & forecasts by Application 2018-2028 (USD Billion)

TABLE 5. Global Ophthalmic Eye Drops market estimates & forecasts by Purchase Mode 2018-2028 (USD Billion)

TABLE 6. Global Ophthalmic Eye Drops market estimates & forecasts by Eye Disease 2018-2028 (USD Billion)

TABLE 7. Global Ophthalmic Eye Drops market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global Ophthalmic Eye Drops market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global Ophthalmic Eye Drops market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global Ophthalmic Eye Drops market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global Ophthalmic Eye Drops market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global Ophthalmic Eye Drops market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global Ophthalmic Eye Drops market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global Ophthalmic Eye Drops market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global Ophthalmic Eye Drops market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. Global Ophthalmic Eye Drops market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. U.S. Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 18. U.S. Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 19. U.S. Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 20. Canada Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 21. Canada Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 22. Canada Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 23. UK Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 24. UK Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 25. UK Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 26. Germany Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 27. Germany Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 28. Germany Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 29. RoE Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 30. RoE Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 31. RoE Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 32. China Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 33. China Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 34. China Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 35. India Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 36. India Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 37. India Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 38. Japan Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 39. Japan Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 40. Japan Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 41. RoAPAC Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 42. RoAPAC Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 43. RoAPAC Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 44. Brazil Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 45. Brazil Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 46. Brazil Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 47. Mexico Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 48. Mexico Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 49. Mexico Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 50. RoLA Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 51. RoLA Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 52. RoLA Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 53. Row Ophthalmic Eye Drops market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 54. Row Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 55. Row Ophthalmic Eye Drops market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 56. List of secondary sources, used in the study of global Ophthalmic Eye Drops market

TABLE 57. List of primary sources, used in the study of global Ophthalmic Eye Drops market

TABLE 58. Years Considered for the study

TABLE 59. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390